Published in Cancer Weekly, May 18th, 1998
Terry L. Timme and a team of researchers from numerous institutions evaluated the safety and potential toxicity of an adenoviral (ADV) vector containing the HSVtk gene in a clinically relevant murine model ("Local Inflammatory Response and Vector Spread after Direct Intraprostatic Injection of a Recombinant Adenovirus Containing the Herpes Simplex Virus Thymidine Kinase Gene and Ganciclovir Therapy in Mice," Cancer Gene Therapy, March/April 1998;5(2):74-82).
"In support of our ongoing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.